Results for
"[search-keyword]"
Sponsor content
45 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PADCEV enfortumab vedotin 20 mg powder for injection vial.
-
Australian Public Assessment Report (AusPAR)AusPAR for Padcev (Enfortumab vedotin) for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed receptor-1 or programmed death-ligand-1 inhibitor.
-
Prescription medicine decision summaryPadcev (enfortumab vedotin) is approved to treat adult patients with locally advanced or metastatic urothelial cancer.
-
Prescription medicine registrationActive ingredients: enfortumab vedotin.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOSPATA gilteritinib (as fumarate) 40 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ADVAGRAF XL tacrolimus 3 mg prolonged-release capsules blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PROGRAF XL tacrolimus 3 mg prolonged-release capsules blister pack.
-
Australian Public Assessment Report (AusPAR)New AusPAR for Xospata (gilteritinib as fumarate) for the treatment of relapsed or refractory acute myeloid leukaemia (AML)
-
-
Prescription medicine registrationActive ingredients: gilteritinib fumarate.